Endolysins as emerging alternative therapeutic agents to counter drug-resistant infections

2019/11/09 by Vijay Singh Gondil, Kusum Harjai, Sanjay Chhibber · 28 citations
Environmental Science · Agricultural and Biological Sciences · Medicine · #Bacteriophages and microbial interactions #Plant Virus Research Studies #Viral gastroenteritis research and epidemiology

paper · doi:10.1016/j.ijantimicag.2019.11.001

Cited by

• Delivery of endolysin across outer membrane of Gram-negative bacteria using translocation domain of botulinum neurotoxin
• C‐terminal anchor endolysins—proposing a third class of tailed bacteriophage endolysins
• Antibacterial Activity of a Fused Endolysin ENDO ‐1252/ KL9P Against Multiple Serovars of Salmonella enterica
• Strategies to Combat Multidrug-Resistant and Persistent Infectious Diseases. [europepmc]
• Bacteriophage endolysins as a potential weapon to combat Clostridioides difficile infection. [europepmc]
• Bacillus-infecting bacteriophage Izhevsk harbors thermostable endolysin with broad range specificity. [europepmc]
• Phage-Encoded Endolysins. [europepmc]
• A Novel Acinetobacter baumannii Bacteriophage Endolysin LysAB54 With High Antibacterial Activity Against Multiple Gram-Negative Microbes. [europepmc]
• Comparison of Enterococcus faecalis Biofilm Removal Efficiency among Bacteriophage PBEF129, Its Endolysin, and Cefotaxime. [europepmc]
• Synergistic action of phage phiIPLA-RODI and lytic protein CHAPSH3b: a combination strategy to target Staphylococcus aureus biofilms. [europepmc]
• Engineered endolysin-based "artilysins" for controlling the gram-negative pathogen Helicobacter pylori. [europepmc]
• A Highly Active Chimeric Lysin with a Calcium-Enhanced Bactericidal Activity against Staphylococcus aureus In Vitro and In Vivo. [europepmc]
• Bacteriophage and Endolysin Encapsulation Systems: A Promising Strategy to Improve Therapeutic Outcomes. [europepmc]
• Current Status of Endolysin-Based Treatments against Gram-Negative Bacteria. [europepmc]
• Treating Bacterial Infections with Bacteriophage-Based Enzybiotics: In Vitro, In Vivo and Clinical Application. [europepmc]
• How Good are Bacteriophages as an Alternative Therapy to Mitigate Biofilms of Nosocomial Infections. [europepmc]
• Diversity of the lysozyme fold: structure of the catalytic domain from an unusual endolysin encoded by phage Enc34. [europepmc]
• The Role of Antimicrobial Peptides as Antimicrobial and Antibiofilm Agents in Tackling the Silent Pandemic of Antimicrobial Resistance. [europepmc]
• Phage Products for Fighting Antimicrobial Resistance. [europepmc]
• Engineering of lysin by fusion of antimicrobial peptide (cecropin A) enhances its antibacterial properties against multidrug-resistant Acinetobacter baumannii . [europepmc]
• Current Treatment Strategies Against Multidrug-Resistant Bacteria: A Review. [europepmc]
• Pseudomonas Phage ZCPS1 Endolysin as a Potential Therapeutic Agent. [europepmc]
• The applications of animal models in phage therapy: An update. [europepmc]
• PlyKp104, a Novel Phage Lysin for the Treatment of Klebsiella pneumoniae, Pseudomonas aeruginosa, and Other Gram-Negative ESKAPE Pathogens. [europepmc]
• Beyond antibiotics: phage-encoded lysins against Gram-negative pathogens. [europepmc]
• A comprehensive review of the applications of bacteriophage-derived endolysins for foodborne bacterial pathogens and food safety: recent advances, challenges, and future perspective. [europepmc]
• Agents Targeting the Bacterial Cell Wall as Tools to Combat Gram-Positive Pathogens. [europepmc]
• The Unique Capability of Endolysin to Tackle Antibiotic Resistance: Cracking the Barrier. [europepmc]